- Presentations
- 2
- Markets
- 1
Lazcluze is a brand of Lazertinib marketed by Janssen Biotech, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Lazertinib
- Brand owner
- Janssen Biotech
- Registered in
- United States
- Strengths and forms
- 240 mg tablet, 80 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Lazcluze 240 mg tabletOral | Janssen Biotech | US FDA | Available on request |
| Lazcluze 80 mg tabletOral | Janssen Biotech | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Lazcluze
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.